The medication Invokana (canagliflozin) is used to assist in the regulation of blood sugar for patients with type 2 diabetes. This medicine has been linked to a number of serious side effects, including a doubled risk of amputation. If you, or a loved one, have taken or are still taking this medication, you should consult with an attorney specializing in dangerous and defective drugs.
Meinhart, Smith & Manning, PLLC of Louisville, KY will meet with you in a private, free consultation to explore your legal rights surrounding Invokana use. Call today to schedule an appointment with one of our leading attorneys.
The Food and Drug Administration (FDA) issued a safety communication on May 15, 2015 regarding the serious conditions that are associated with Invokana and other SGLT2 inhibitors.
The risks of this dangerous medication include:
Diabetic ketoacidosis (DKA) can be a life threatening, and sometimes fatal, condition. If insulin levels in the body are too low, dangerous levels of ketones (acids) accumulate in the blood cells. This condition is called ketoacidosis and can require emergency hospitalization, lead to a diabetic coma, and in some cases, even cause death. Symptoms of ketoacidosis include:
The condition develops slowly, but eventually the combination of dehydration, low blood sugar, shock and fatigue results in devastating consequences for the patient.
An additional FDA safety announcement was issued in May 2016. This notice was issued to warn the public about the risk of amputation associated with Invokana. Results of an investigation revealed that patients who were using Invokana had double the risk of amputation as patients who received a placebo.
The most common amputations were for the middle of the foot and the toe. Amputations of the leg, above and below the knee, also occurred. In the most severe cases, some patients’ loss multiple limbs to amputation.
It is not clear yet just how the drug leads to amputations but some doctors think that it may cause a patient’s blood to thicken and pool in the lower extremities. Although the cause hasn’t been defined, there may be factors that increase the risk of amputation for those taking Invokana, according to the FDA. These risk factors could include: any prior amputation history, neuropathy, peripheral vascular disease, and diabetic foot ulcers.
Many doctors are taking their patients off of the drug as a result of these revelations. Kaiser Permanente in California notified its doctors of the names of patients who were taking the drug and suggested that they discontinue its use for patients with certain conditions. The Veterans Health Administration (VA) does not have the drug on its formulary.
People who are taking this medication need to be mindful of their bodies and report changes to their doctors immediately. Carefully monitor the following symptoms in the lower extremities:
The medication should not be stopped abruptly without consulting a doctor. Stopping a diabetes medication can result in uncontrolled blood sugar levels. When blood sugar is not controlled properly, complications such as heart disease, nerve damage, kidney damage, or blindness can result.
If you are currently taking Invokana or have taken it in the past, it is wise to consult with an Louisville product liability attorney. The attorneys at Meinhart, Smith & Manning, PLLC are experienced in working with medical and research professionals to prove a causal relationship between the dangerous medication and the injury sustained by their client. Call us right away for a free case evaluation and to find out what your rights are.